Amped PCR
Cardiff
About Amped PCR
Amped PCR are reagent manufacturers and developing PurifAI - a platform for detecting pathogens and AMR in real time replacing slow, culture-based lab tests with qPCR, sequencing, and cloud analytics. This enables rapid, scalable surveillance across applied markets such as Agri-Food, Environmental, and Veterinary.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $912.0K
- Funding stage: Seed
- Last round: Seed (Dec 2024)
- Website: ampedpcr.co.uk
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Machine Learning, Machinery Manufacturing, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/amped-pcr-42934 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.